Thanks. The newfound push toward public disclosure of clinical data—including data from failed and earlier-stage studies—would seem to be at odds with the traditional view on this matter.
Nice research, nice find. I think Dew raises an interesting point about the information you posted being reconciled with the demand from the public (patients and doctors) and from the media (and, possibly, from politicians) about the need for more transparency regarding clinical trials.
Market Data 
Markets 
AI
